Review article: prevention, diagnosis and management of COVID-19 in the IBD patient.

ABSTRACT:

Background

The current COVID-19 pandemic, caused by SARS-CoV-2, has emerged as a public health emergency. All nations are seriously challenged as the virus spreads rapidly across the globe with no regard for borders. The primary management of IBD involves treating uncontrolled inflammation with most patients requiring immune-based therapies. However, these therapies may weaken the immune system and potentially place IBD patients at increased risk of infections and infectious complications including those from COVID-19.

Aim

To summarise the scale of the COVID-19 pandemic, review unique concerns regarding IBD management and infection risk during the pandemic and assess COVID-19 management options and drug interactions in the IBD population.

Methods

A literature review o

SUBMITTER: Al-Ani AH 

PROVIDER: S-EPMC7267115 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature